Skip to main content

What the FDA labels say about taking them together

Eplontersen and vitamin a

Eplontersen's FDA label of April 15, 2026 names vitamin a in its warnings and precautions section; the vitamin a label PlainMeds reads does not name eplontersen. The eplontersen label: “WARNINGS AND PRECAUTIONS Reduced Serum Vitamin A Levels and Recommended Supplementation: Supplement with the recommended daily allowance of vitamin A. …”

Check it at the source: the eplontersen FDA label on DailyMed (effective April 15, 2026, AstraZeneca Pharmaceuticals LP); the vitamin a FDA label on DailyMed (effective March 3, 2026, Rising Pharma Holdings, Inc.).

What does the eplontersen label say about vitamin a?

Eplontersen label, warnings and precautions

WARNINGS AND PRECAUTIONS Reduced Serum Vitamin A Levels and Recommended Supplementation: Supplement with the recommended daily allowance of vitamin A. Refer to an ophthalmologist if ocular symptoms suggestive of vitamin A deficiency occur.

Source: FDA drug label (WAINUA), AstraZeneca Pharmaceuticals LP, effective April 15, 2026 (SPL set d7dcb847-71dd-4fff-82d0-d43a465fc096), via openFDA; the full label on DailyMed

What does the vitamin a label say about eplontersen?

Vitamin a's label (effective March 3, 2026) does not name eplontersen in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (AQUASOL A Parenteral), Rising Pharma Holdings, Inc., effective March 3, 2026 (SPL set 1abd66eb-6ac8-4a9e-a609-251e46ea1a27), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Eplontersen generic labelers
0Vitamin a generic labelers
EplontersenVitamin a
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?